Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT05313087
COVID-19 Vaccine Response in Chronic Respiratory Conditions
Sponsor: National Jewish Health
View on ClinicalTrials.gov
Summary
The investigators will assess the antibody, T cell and B cell responses to SARS-CoV-2 vaccination before and every 3 months for 18 months after the initial vaccination or subsequent vaccinations (boosters) in adults and children including patients with chronic medical conditions.
Official title: COVID-19 Vaccine Response and Durability In Patients With Chronic Respiratory and Medical Disorders
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
360
Start Date
2021-02-03
Completion Date
2023-12-30
Last Updated
2026-04-20
Healthy Volunteers
Yes
Conditions
Interventions
BIOLOGICAL
COVID-19 vaccine
assess response to vaccine
Locations (1)
National Jewish Health
Denver, Colorado, United States